Cook Will Appeal Ruling Against Guidant Paclitaxel Stent Distribution
This article was originally published in The Gray Sheet
Executive Summary
Guidant has vowed to "define an organizational construct" that "allows for the commercialization of paclitaxel-eluting stents," following a June 13 court ruling against its Cook distribution agreement for access to the drug